These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 815534)

  • 1. Cross-reactivity of lytic antibodies against blood forms of Trypanosoma cruzi.
    Kierszenbaum F
    J Parasitol; 1976 Feb; 62(1):134-5. PubMed ID: 815534
    [No Abstract]   [Full Text] [Related]  

  • 2. Lack of cross-reactivity of lytic antibodies with bloodstream forms of Trypanosoma cruzi zymodemes generated in a mouse experimental model.
    Wallace A; Sanchez G; Venegas J; Solari A
    Exp Parasitol; 1995 Mar; 80(2):176-85. PubMed ID: 7895829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbohydrate epitopes are responsible for antibody cross-reactivity in Trypanosoma cruzi-infected mice.
    Xu BX; Powell MR
    J Parasitol; 1991 Oct; 77(5):808-10. PubMed ID: 1717672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immune response to Trypanosoma cruzi. An approach to the pathogenesis of Chagas' disease].
    Braun M; de Titto E
    Acta Physiol Pharmacol Latinoam; 1985; 35(1):1-47. PubMed ID: 2932884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Exoantigens of Trypanosoma cruzi. Epitopes reactive against immunoglobulins of patients with Chagas' disease].
    Gruppi A; Moretti ER; Basso B; Vottero-Cima E
    Medicina (B Aires); 1988; 48(2):161-6. PubMed ID: 3148093
    [No Abstract]   [Full Text] [Related]  

  • 6. Trypanosoma rangeli: epimastigote immunogenicity and cross-reaction with Trypanosoma cruzi.
    Saldaña A; Sousa OE
    J Parasitol; 1996 Apr; 82(2):363-6. PubMed ID: 8604121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody-independent, natural resistance of birds to Trypanosoma cruzi infection.
    Kierszenbaum F; Gottlieb CA; Budzko DB
    J Parasitol; 1981 Oct; 67(5):656-60. PubMed ID: 6795329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutralizing antibodies in Trypanosoma cruzi infection.
    Sánchez DO; González Cappa SM
    Medicina (B Aires); 1983; 43(1):41-6. PubMed ID: 6410148
    [No Abstract]   [Full Text] [Related]  

  • 9. Partial characterization of a Trypanosoma cruzi-released decomplementing factor.
    Cunningham DS; Brewer TE; Kuhn RE; Craig WH
    J Parasitol; 1981 Aug; 67(4):475-80. PubMed ID: 6790694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies against endocardium, vascular structures, and interstitium of striated muscle that cross-react with T. cruzi and T. rhodesiense.
    Szarfman A; Cossio PM; Diez C; Arana RM; Sadun E
    J Parasitol; 1974 Dec; 60(6):1024. PubMed ID: 4140227
    [No Abstract]   [Full Text] [Related]  

  • 11. Autoantibodies in Chagas' disease. An antibody cross-reactive with human and Trypanosoma cruzi ribosomal proteins.
    Bonfa E; Viana VS; Barreto AC; Yoshinari NH; Cossermelli W
    J Immunol; 1993 May; 150(9):3917-23. PubMed ID: 8473740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of acute infection by Trypanosoma cruzi upon the response of mice to sheep erythrocytes.
    Schmuñis GA; Szarfman A; Pesce UJ; González-Cappa SM
    Rev Inst Med Trop Sao Paulo; 1977; 19(5):323-31. PubMed ID: 416482
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of complement depletion in experimental chagas disease: immune lysis of virulent blood forms of Trypanosoma cruzi.
    Budzko DB; Pizzimenti MC; Kierszenbaum F
    Infect Immun; 1975 Jan; 11(1):86-91. PubMed ID: 46840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Wild reservoirs and vectors of Trypanosoma cruzi. LXXIII: Resistance against wild strains of T. cruzi in mice inoculated with Herpetomas samuelpessoai].
    Belda Neto FM; Ribeiro RD; Barretto MP
    Rev Bras Biol; 1979 Mar; 39(1):209-14. PubMed ID: 111309
    [No Abstract]   [Full Text] [Related]  

  • 15. [The diagnosis of chronic Chagas disease using recombinant antigens of Trypanosoma cruzi].
    Lorca M; González A; Reyes V; Veloso C; Vergara U; Frasch C
    Rev Med Chil; 1993 Apr; 121(4):363-8. PubMed ID: 8272605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of antibody cross-reactivity in experimental American trypanosomiasis.
    Rosfjord EC; Mikhail KS; Rowland EC; Powell MR
    J Parasitol; 1990 Oct; 76(5):698-702. PubMed ID: 1698959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for cross-reactivity between antigen derived from Trypanosoma cruzi and myelin basic protein in experimental Chagas disease.
    Al-Sabbagh A; Garcia CA; Diaz-Bardales BM; Zaccarias C; Sakurada JK; Santos LM
    Exp Parasitol; 1998 Jul; 89(3):304-11. PubMed ID: 9676708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of complement levels in mice infected with Trypanosoma cruzi.
    Cunningham DS; Craig WH; Kuhn RE
    J Parasitol; 1978 Dec; 64(6):1044-9. PubMed ID: 105116
    [No Abstract]   [Full Text] [Related]  

  • 19. [Study of cases of leishmaniasis in the Province of Salta: evidences of mixed infection with Trypanosoma cruzi and Leishmania spp].
    Chiaramonte MG; Zwirner NW; Caropresi SL; Heredia V; Taranto NJ; Malchiodi EL
    Medicina (B Aires); 1996; 56(3):259-68. PubMed ID: 9035482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement of cytolytic antibody in experimental Chagas' disease using a terminal radiolabelling procedure.
    Powell MR; Kuhn RE
    J Parasitol; 1980 Jun; 66(3):399-406. PubMed ID: 6771377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.